Autopsy report · NCT00852332
Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer
Cause of deathFutility
“The trial was stopped for futility in view of the results of the anticipated analysis”
Life of this trial
- Registered 6 months before it started.
- Ran for about 8 years 3 months before it stopped.
- 42 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Centre Jean Perrin
- Sponsor type
- University, hospital or other
- Conditions
- Breast Cancer
- Interventions
- Curcumin; Taxotere
- Participants
- 42
- Sites
- 1
- Countries
- France
Trials that died the same way
- Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer
“Futility analysis did not support continuation of the trial” - An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
“An independent assessment concluded the trial was not likely to meet the primary endpoint upon completion and therefore, trial stopped for futility” - Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
“This trial was terminated following a futility analysis confirming futility of continuing the study” - Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
“Trial stopped for futility” - Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP
“The trial was stopped earlier than planned after an ad hoc interim analysis”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.